Literature DB >> 11165443

Group I metabotropic glutamate receptors prevent endothelial programmed cell death independent from MAP kinase p38 activation in rat.

S H Lin1, K Maiese.   

Abstract

Activation of Group I metabotropic glutamate receptors (mGluRs) prevents neuronal programmed cell death (PCD), but the role of these receptors in the vascular endothelial cell (EC) system has not been defined. Since ECs are principal targets for ischemic free radical injury, we examined whether the mGluR system could modulate vascular PCD. Activation of the Group I mGluR system, but not antagonism, addressed two distinct pathways of PCD by preventing the destruction of genomic DNA and maintaining EC membrane asymmetry. The induction of nitric oxide (NO)-induced PCD in ECs paralleled the specific activation of the MAP kinase p38 pathway, but the vascular protection conferred by the Group I mGluR system appears to rely on more downstream cellular pathways. We provide initial evidence for Group I mGluRs to prevent NO-induced vascular injury and offer new directions for vascular disease treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165443     DOI: 10.1016/s0304-3940(00)01766-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

Review 1.  Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li
Journal:  Curr Neurovasc Res       Date:  2005-12       Impact factor: 1.990

Review 2.  Therapeutic promise and principles: metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

Review 3.  Mechanistic insights into diabetes mellitus and oxidative stress.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

4.  Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer.

Authors:  Cecilia L Speyer; Ali H Hachem; Ali A Assi; Jennifer S Johnson; John A DeVries; David H Gorski
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

5.  Genetic variants of glutamate receptor gene family in Taiwanese Kawasaki disease children with coronary artery aneurysms.

Authors:  Ying-Ju Lin; Jeng-Sheng Chang; Xiang Liu; Hsinyi Tsang; Ting-Hsu Lin; Chiu-Chu Liao; Shao-Mei Huang; Wen-Kuei Chien; Jin-Hua Chen; Jer-Yuarn Wu; Chien-Hsiun Chen; Li-Ching Chang; Cheng-Wen Lin; Tsung-Jung Ho; Fuu-Jen Tsai
Journal:  Cell Biosci       Date:  2014-11-19       Impact factor: 7.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.